期刊文献+

系统性红斑狼疮合并抗磷脂综合征患者的临床分析 被引量:3

Clinical characteristics of 39 patients with systemic lupus erythematosus and antiphospholipid syndrome
原文传递
导出
摘要 目的 研究系统性红斑狼疮合并抗磷脂综合征(SLE-APS)患者的临床特点.方法 对39例SLE-APS患者的临床和实验室资料进行回顾性分析.结果 39例患者中,有31例共发生了48次血栓栓塞事件,以深静脉血栓及脑梗死为主.26例已婚有生育史女性患者中,有12例发生病态妊娠.28例抗心磷脂抗体阳性 16例狼疮抗凝物阳性.24例患者先确诊SLE,平均9.5年后又出现APS样表现 12例先出现反复病态妊娠或血栓事件,平均4.8年后演变为SLE 3例一发病便同时符合SLE和APS的分类标准.有5例在发生血栓事件或病态妊娠时的狼疮活动指数〈5分.结论 SLE-APS患者血栓事件及病态妊娠发生率增多.APS可出现于SLE之前、之后或同时.狼疮患者可以在病情稳定期出现APS的表现.详细询问病史、常规检测抗心磷脂抗体,有助于发现SLE-APS的高危因素,积极预防APS的发生. Objective To understand the clinical characteristics of systemic lupus erythematosus with Antiphospholipid syndrome (SLE-APS).Methods The clinical data of 39 cases of SLE-APS were collected and analyzed retrospectively. Results Thirty-one patients had 48 thrombosis episodes in total, among which the most common presenting manifestations were deep venous thrombosis and stroke. 12 of 26 married women had fetal morbidity. The prevalence of anticardio lipin antibody (aCL) and lupus anticoagulant ( LA) was 72% and 41% , respectively. 24 patients had SLE at first,on an average of 9. 5 years later they had the characteristics of APS, 12 patients had thrombosis episodes or fetal morbidities ,4. 8 years later they developed into SLE,and 3 patients had the characteristics of SLE and APS from the onset The SLEDAI was less than 5 in five cases when they had thrombosis episodes or fetal morbidities.Conclusions The incidence of thrombosis episodes or fetal morbidities increased in SLE-APS patients. APS occurred before, after or at the same time with SLE. SLE patients might have the clinical features of APS during the steady stage. It's very important to ask the medical history in detail and measure aCL in lupus patients to find the risk factor of APS and prevent the APS' occurrence.
出处 《中国综合临床》 2010年第7期746-748,共3页 Clinical Medicine of China
关键词 系统性红斑狼疮 抗磷脂综合征 抗心磷脂抗体 Systemic lupus erythematosus Antiphospholipid syndrome Anticardiolipin antibody
  • 相关文献

参考文献10

  • 1Miyakis S,Lockshin MD,Atsumi T,et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J].J Thromb Haemost,2006,4 (2):295-306.
  • 2李坦,吴竞生.抗磷脂综合征的研究进展[J].血栓与止血学,2008,14(2):85-87. 被引量:7
  • 3Galli M,Luciani D,Bertolini G,et al.Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome:a systematic review of the literature[J].Blood,2003,101(5):1827-1832.
  • 4Aung W,Murata Y,Ishida R,et al.Comparison of lung perfusion scintigraphic findings in pulmonary thromboembolism in systemic lupus erythematosus,SLE plus antiphospholipid syndrome,and primary antiphospholipid syndrome[J].Nucl Med Commun,2000,21(3):299-304.
  • 5Chaves CJ.Stroke in Patients with Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome[J].Curr Treat Options Cardiovasc Med,2004,6(3):223-229.
  • 6钱捷,陈晓翔,李树杰,吴美芳,曾婷,邹玉琼,顾越英,王元,鲍春德,陈顺乐,杨程德.抗磷脂综合征115例的临床特点及临床分类标准的演变和局限性的探讨[J].中华风湿病学杂志,2007,11(6):324-327. 被引量:5
  • 7王纯巍,李晓娟,唐宝伟.80例系统性红斑狼疮患者支原体感染情况分析[J].解放军医学杂志,2008,33(6):718-718. 被引量:7
  • 8Cordeiro A,Lermann R,Ambrosio P,et al.Pregnancy and antiphospholipid antibodies in systemic lupus erithematosus patients:an outcome evaluation[J].Acta Reumatol Port,2009,34 (3):486-491.
  • 9孙明丽,陈美璞,李世雪,宋杰,李运智.中性粒细胞碱性磷酸酶活性测定对系统性红斑狼疮的诊断价值[J].中国基层医药,2008,15(3):394-395. 被引量:1
  • 10Hanly JG.Antiphospholipid syndrome:an overview[J].CMAJ,2003,168(13):1675-1682.

二级参考文献37

共引文献16

同被引文献29

  • 1郭强,顾越英,黄文群,杨程德,吴华伟,鲍春德,王元,许建荣,陈顺乐.系统性红斑狼疮患者525例肺部病变的调查[J].中华风湿病学杂志,2004,8(6):363-366. 被引量:29
  • 2Spiegel J, Ishimori ML, Wallace D J, et al. The lowest surviving birth weight reported in a systemic lupus eryth ematosus patient:a review of the literature. Lupus ,2007,16:52-55.
  • 3Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies In- cluding Therapeutics. Ann Rheum Dis ,2008,67 : 195-205.
  • 4Smyth A,Oliveira GH,Lahr BD,et al. A systematic review and meta-a- nalysis of pregnancy outcomes in patients with systemic lupus erythema- tosus and lupus nephritis. Clin J Am Soc Nephro1,2010,5:2060-2068.
  • 5Ko HS, Ahn Jang DG, Choi SK, et al. Pregnancy outcomes and appropri- ate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci,2011,8 :577-583.
  • 6Clowse ME. Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumati1,2010 ,24 :373-385.
  • 7Ye H, Chen S, An Y. Maternal and fetal Outcomes in systemic lupus er- ythematosus :analysis of 41 Patients. Beijing Da Xue Xue Bao, 2012, 44:233-235.
  • 8Siu BW,Chow HM, Kwok SS, et al. Systemic lupus erythematosus as a cause of first-episode psychosis in the second trimester of pregnancy. East Arch psychiatry ,2010,20 : 145-150.
  • 9Marker-Hermann E, Fischer-Betz R. Rheumatic diseases and pregnan- cy. Curt Opin Obstet Gyneco1,2010 ,22 :458-465.
  • 10Clowse ME, Magder LS, Witter F, et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol,2006,107 (2 pt 1 ) :293-299.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部